WEST PHARMACEUTICAL SERVICES (WST) Stock Overview
NYSE:WST - US9553061055 - Common Stock
WST Key Statistics, Chart & Performance
The current stock price of WST is 247.85 USD. In the past month the price decreased by -5.94%. In the past year, price decreased by -18.14%.
WST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.84 | 188.74B | ||
| DHR | DANAHER CORP | 28.13 | 151.66B | ||
| A | AGILENT TECHNOLOGIES INC | 22.52 | 34.55B | ||
| IQV | IQVIA HOLDINGS INC | 16.67 | 32.50B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 32.31 | 27.46B | ||
| WAT | WATERS CORP | 24.71 | 17.99B | ||
| ILMN | ILLUMINA INC | 24.47 | 16.11B | ||
| TEM | TEMPUS AI INC | N/A | 13.94B | ||
| ICLR | ICON PLC | 13.29 | 13.67B | ||
| MEDP | MEDPACE HOLDINGS INC | 34.47 | 13.02B | ||
| RVTY | REVVITY INC | 19.25 | 11.10B | ||
| QGEN | QIAGEN N.V. | 21.17 | 10.77B |
Related stock screener links
About WST
Company Profile
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Company Info
WEST PHARMACEUTICAL SERVICES
530 Herman O. West Drive
Exton PENNSYLVANIA 19341 US
CEO: Eric M. Green
Employees: 10600
Phone: 16105942900
WEST PHARMACEUTICAL SERVICES / WST FAQ
What is the stock price of WEST PHARMACEUTICAL SERVICES today?
The current stock price of WST is 247.85 USD. The price increased by 2.15% in the last trading session.
What is the ticker symbol for WEST PHARMACEUTICAL SERVICES stock?
The exchange symbol of WEST PHARMACEUTICAL SERVICES is WST and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is WST stock listed?
WST stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for WEST PHARMACEUTICAL SERVICES stock?
19 analysts have analysed WST and the average price target is 320.54 USD. This implies a price increase of 29.33% is expected in the next year compared to the current price of 247.85. Check the WEST PHARMACEUTICAL SERVICES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is WEST PHARMACEUTICAL SERVICES worth?
WEST PHARMACEUTICAL SERVICES (WST) has a market capitalization of 17.82B USD. This makes WST a Large Cap stock.
How many employees does WEST PHARMACEUTICAL SERVICES have?
WEST PHARMACEUTICAL SERVICES (WST) currently has 10600 employees.
What are the support and resistance levels for WEST PHARMACEUTICAL SERVICES (WST) stock?
WEST PHARMACEUTICAL SERVICES (WST) has a support level at 237.27 and a resistance level at 250.97. Check the full technical report for a detailed analysis of WST support and resistance levels.
Is WEST PHARMACEUTICAL SERVICES (WST) expected to grow?
The Revenue of WEST PHARMACEUTICAL SERVICES (WST) is expected to grow by 4.98% in the next year. Check the estimates tab for more information on the WST EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy WEST PHARMACEUTICAL SERVICES (WST) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of WST, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of WST, evaluating the profitability, health, valuation and growth aspects
- WEST PHARMACEUTICAL SERVICES (WST) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- WEST PHARMACEUTICAL SERVICES (WST) Sales and EPS estimates to see what analysts future expectations are.
- WEST PHARMACEUTICAL SERVICES (WST) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- WEST PHARMACEUTICAL SERVICES (WST) Insider and Institutional Ownership to learn about the owners and their transactions.
- WEST PHARMACEUTICAL SERVICES (WST) Stock Chart to make your own analysis
- WEST PHARMACEUTICAL SERVICES (WST) Latest news and press-releases to stay up to date.
Does WEST PHARMACEUTICAL SERVICES (WST) stock pay dividends?
WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.37%. The yearly dividend amount is currently 0.81. Check the full fundamental report for a detailed analysis of WST dividend history, reliability and sustainability.
When does WEST PHARMACEUTICAL SERVICES (WST) report earnings?
WEST PHARMACEUTICAL SERVICES (WST) will report earnings on 2025-10-22, before the market open.
What is the Price/Earnings (PE) ratio of WEST PHARMACEUTICAL SERVICES (WST)?
The PE ratio for WEST PHARMACEUTICAL SERVICES (WST) is 35.61. This is based on the reported non-GAAP earnings per share of 6.96 and the current share price of 247.85 USD. Check the full fundamental report for a full analysis of the valuation metrics for WST.
What is the Short Interest ratio of WEST PHARMACEUTICAL SERVICES (WST) stock?
The outstanding short interest for WEST PHARMACEUTICAL SERVICES (WST) is 3.03% of its float. Check the ownership tab for more information on the WST short interest.
WST Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to WST. When comparing the yearly performance of all stocks, WST is a bad performer in the overall market: 62.09% of all stocks are doing better.
WST Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to WST. Both the health and profitability get an excellent rating, making WST a very profitable company, without any liquidiy or solvency issues.
WST Financial Highlights
Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 6.96. The EPS decreased by -1.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.48% | ||
| ROA | 12.34% | ||
| ROE | 16.65% | ||
| Debt/Equity | 0.07 |
WST Forecast & Estimates
19 analysts have analysed WST and the average price target is 320.54 USD. This implies a price increase of 29.33% is expected in the next year compared to the current price of 247.85.
For the next year, analysts expect an EPS growth of -6.1% and a revenue growth 4.98% for WST